home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Regulating Insensitivity To DNA Damage

  June, 14 2007 20:00
your information resource in human molecular genetics
A protein commonly associated with B cell lymphomas suppresses elimination of 'useful' B cells that otherwise harbor damaged DNA, suggests a report published online in Nature Immunology.

In most cells, DNA damage triggers 'sensors' to halt cellular activity until the DNA damage is repaired. Ari Melnick and colleagues find that the protein Bcl-6 prevents the production of the DNA damage sensor, called ATR, in a select group of B cells called germinal center (GC) cells, which produce antibodies. In this setting Bcl-6 is beneficial to B cells that encounter foreign antigen and then undergo highly focused DNA mutations in antibody-encoding genes, a process normally required to generate highly effective antibodies. However, such DNA mutations can also lead to GC B cell death, potentially reducing the production of useful antibodies.

Melnick's group shows that Bcl-6 can suppress activity of the ATR gene, which effectively 'turns off' the DNA damage sensor machinery and leaves the mutated GC B cells less prone to DNA damage-induced death. More generally, many B cell lymphomas display deregulated Bcl-6 expression and tolerate excessive DNA mutations, including those generated by radiation treatments. The new work suggests that manipulating Bcl-6 in lymphoma cells might render them more sensitive to irradiation.

Author contact:

Ari Melnick (Albert Einstein College of Medicine, Bronx, NY, USA)
Email: amelnick@aecom.yu.edu

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.